Literature DB >> 1824924

Activation and cytotoxicity of 5'-deoxy-5-fluorouridine in c-H-ras transformed NIH 3T3 cells.

Y Geng1, E Gheuens, E A de Bruijn.   

Abstract

Transformation of NIH 3T3 cells with c-H-ras has been demonstrated to result in significantly increased activation of 5'-deoxy-5-fluorouridine and significantly increased cytotoxicity in vitro as compared to non-transformed NIH 3T3. FUra cytotoxicity appeared to be increased also in vitro upon transformation; the level of significance however was beyond that of accepted significance (0.05 less than P less than 0.01). Furthermore dFUrd proved to be less active in vivo in nude mice bearing v-fos transformed NIH 3T3 cells than in nude mice bearing c-H-ras transformed cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1824924     DOI: 10.1016/0006-2952(91)90490-v

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  3 in total

1.  Pharmacokinetics and bioavailability of oral 5'-deoxy-5-fluorouridine in cancer patients.

Authors:  S A Van Der Heyden; M S Highley; E A De Bruijn; U R Tjaden; H J Reeuwijk; H Van Slooten; A T Van Oosterom; R A Maes
Journal:  Br J Clin Pharmacol       Date:  1999-04       Impact factor: 4.335

2.  5'-Deoxy-5-fluorouridine increases daunorubicin uptake in multidrug-resistant cells and its activity is related with P-gp 170 expression.

Authors:  S van der Heyden; E Gheuens; W van de Vrie; D Van Bockstaele; A Van Oosterom; A Eggermont; E A De Bruijn
Journal:  Jpn J Cancer Res       Date:  1994-01

3.  Cytokines induce uridine phosphorylase in mouse colon 26 carcinoma cells and make the cells more susceptible to 5'-deoxy-5-fluorouridine.

Authors:  H Eda; K Fujimoto; S Watanabe; T Ishikawa; T Ohiwa; K Tatsuno; Y Tanaka; H Ishitsuka
Journal:  Jpn J Cancer Res       Date:  1993-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.